Kiromic BioPharma, Inc.
KRBPQ
$0.0615
-$0.083-57.44%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.49M | -7.43M | -6.83M | -6.15M | -4.69M |
| Total Depreciation and Amortization | 568.00K | 552.00K | 557.00K | 557.00K | 555.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.13M | 478.00K | 185.00K | 211.00K | 2.00M |
| Change in Net Operating Assets | -1.86M | 4.47M | -2.10M | -319.00K | -3.28M |
| Cash from Operations | -3.65M | -1.93M | -8.18M | -5.70M | -5.41M |
| Capital Expenditure | -28.00K | -219.00K | -98.00K | -21.00K | -109.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -28.00K | -219.00K | -98.00K | -21.00K | -109.00K |
| Total Debt Issued | 2.50M | 1.12M | 8.88M | 6.40M | 4.40M |
| Total Debt Repaid | -85.00K | -96.00K | -96.00K | -208.00K | -57.00K |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -1.00K |
| Cash from Financing | 2.42M | 1.03M | 8.78M | 6.19M | 4.34M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.26M | -1.12M | 503.00K | 472.00K | -1.18M |